Bausch Health Companies Inc

Bausch Health Companies Inc

BHC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.13B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bausch Health Companies IncBausch Health Companies Inc-3.7-61%0.3-15.6
$8.50

Target Price by Analysts

1.9% upsideBausch Health Companies Target Price DetailsTarget Price
$12.39

Current Fair Value

48.5% upside

Undervalued by 48.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.13 Billion
Enterprise Value$21.43 Billion
Earnings per Share$0.43
Beta0.37
Outstanding Shares375,500,000

Return

Return on Equity61.34%ROE
Return on Assets-3.20%
Return on Invested Capital13.66%

Valuation & Multiples

P/E Ratio-3.68P/E Ratio
PEG-2.52PEG
Price to Sales0.32Price to Sales
Price to Book Ratio-8.35Price to Book Ratio
Enterprise Value to Revenue2.15
Enterprise Value to EBIT7.56
Enterprise Value to Net Income-27
Total Debt to Enterprise0.97
Debt to Equity-15.65Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 4, 2026
EPS Estimate
$1.17
Consensus analyst estimate
Revenue Estimate
$2.68 B
Consensus analyst estimate

Next Earnings Call

Expected Date
February 17, 2027
EPS Estimate
$1.31
Consensus analyst estimate
Revenue Estimate
$2.73 B
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 19.50, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.

Put/Call Ratio19.5013▲ 1713.87%
Total Calls112,500▼ 97.09%
Total Puts2,193,900▼ 75.97%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %3.50%▼ 60.32%
Total Invested$85.04M▼ 92.85%
Investors Holding89▼ 154.00%

About Bausch Health Companies Inc

21,100 employees
CEO: Thomas J. Appio

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter ...

Bausch Health Companies Insider Information FAQ

Stockcircle tracks 8 top investors with a current 13F position in Bausch Health Companies. Notable holders include Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions and 1 top investor reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 2 open-market insider sales for Bausch Health Companies in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.